Literature DB >> 25520548

Care at the Crossroads: Navigating the HIV, HCV, and Substance Abuse Syndemic.

Rebecca Reece1, Caitlin Dugdale1, Francine Touzard-Romo1, Amanda Noska1, Timothy Flanigan1, Josiah D Rich1.   

Abstract

For patients with both HIV/HCV coinfection and substance addiction, multidisciplinary teams can facilitate coordination of care and improve clinical outcomes. Such teams should include HIV/HCV treatment providers, mental health specialists, case managers, social workers, and substance abuse counselors.

Entities:  

Year:  2014        PMID: 25520548      PMCID: PMC4266471     

Source DB:  PubMed          Journal:  Fed Pract        ISSN: 1078-4497


  42 in total

Review 1.  HIV/hepatitis C coinfection natural history and disease progression.

Authors:  Maria D Hernandez; Kenneth E Sherman
Journal:  Curr Opin HIV AIDS       Date:  2011-11       Impact factor: 4.283

Review 2.  A situation update on HIV epidemics among people who inject drugs and national responses in South-East Asia Region.

Authors:  Mukta Sharma; Edna Oppenheimer; Tobi Saidel; Virginia Loo; Renu Garg
Journal:  AIDS       Date:  2009-07-17       Impact factor: 4.177

3.  Binge use and sex and drug use behaviors among HIV(-), heterosexual methamphetamine users in San Diego.

Authors:  W Susan Cheng; Richard S Garfein; Shirley J Semple; Steffanie A Strathdee; James K Zians; Thomas L Patterson
Journal:  Subst Use Misuse       Date:  2010       Impact factor: 2.164

4.  Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV.

Authors:  Berkeley N Limketkai; Shruti H Mehta; Catherine G Sutcliffe; Yvonne M Higgins; Michael S Torbenson; Sherilyn C Brinkley; Richard D Moore; David L Thomas; Mark S Sulkowski
Journal:  JAMA       Date:  2012-07-25       Impact factor: 56.272

5.  Delivering care to injection drug users coinfected with HIV and hepatitis C virus.

Authors:  Lynn E Taylor
Journal:  Clin Infect Dis       Date:  2005-04-15       Impact factor: 9.079

Review 6.  HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment.

Authors:  Nick Walsh; Lisa Maher
Journal:  Curr Opin HIV AIDS       Date:  2012-07       Impact factor: 4.283

Review 7.  Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis.

Authors:  Hla-Hla Thein; Qilong Yi; Gregory J Dore; Murray D Krahn
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

8.  Factors associated with engaging socially marginalized HIV-positive persons in primary care.

Authors:  Maureen H Rumptz; Carol Tobias; Serena Rajabiun; Judith Bradford; Howard Cabral; Robin Young; William E Cunningham
Journal:  AIDS Patient Care STDS       Date:  2007       Impact factor: 5.078

Review 9.  The impact of mental health and substance abuse factors on HIV prevention and treatment.

Authors:  James Walkup; Michael B Blank; Jeffrey S Gonzalez; Steven Safren; Rebecca Schwartz; Larry Brown; Ira Wilson; Amy Knowlton; Frank Lombard; Cynthia Grossman; Karen Lyda; Joseph E Schumacher
Journal:  J Acquir Immune Defic Syndr       Date:  2008-03-01       Impact factor: 3.731

10.  The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.

Authors:  Perrine Roux; M Patrizia Carrieri; Virgine Villes; Pierre Dellamonica; Isabelle Poizot-Martin; Isabelle Ravaux; Bruno Spire
Journal:  Addiction       Date:  2008-09-04       Impact factor: 6.526

View more
  4 in total

1.  Integration of care for HIV and opioid use disorder.

Authors:  Benjamin J Oldfield; Nicolas Muñoz; Mark P McGovern; Melissa Funaro; Merceditas Villanueva; Jeanette M Tetrault; E Jennifer Edelman
Journal:  AIDS       Date:  2019-04-01       Impact factor: 4.177

2.  Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial.

Authors:  Sunil Suhas Solomon; Thomas C Quinn; Suniti Solomon; Allison M McFall; Aylur K Srikrishnan; Vinita Verma; Muniratnam S Kumar; Oliver Laeyendecker; David D Celentano; Syed H Iqbal; Santhanam Anand; Canjeevaram K Vasudevan; Shanmugam Saravanan; David L Thomas; Kuldeep Singh Sachdeva; Gregory M Lucas; Shruti H Mehta
Journal:  J Hepatol       Date:  2019-10-08       Impact factor: 25.083

3.  Mobile technology intervention to improve care coordination between HIV and substance use treatment providers: development, training, and evaluation protocol.

Authors:  Kasey Claborn; Sara Becker; Susan Ramsey; Josiah Rich; Peter D Friedmann
Journal:  Addict Sci Clin Pract       Date:  2017-03-14

Review 4.  Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?

Authors:  Katherine M Rich; Joshua Bia; Frederick L Altice; Judith Feinberg
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.